-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Supernus Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2024.
- Supernus Pharmaceuticals, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $153M, a 7.6% decline year-over-year.
- Supernus Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $580M, a 5.33% decline year-over-year.
- Supernus Pharmaceuticals, Inc. annual Costs and Expenses for 2024 was $580M, a 5.33% decline from 2023.
- Supernus Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $613M, a 1.34% decline from 2022.
- Supernus Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $621M, a 25.8% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)